Industrial components manufacturer Synnovia recently discovered a non-material overstatement of revenues linked to its trading year ended 31 March 2018.
Irish engineering group Mincon saw own-brand sales increase in the first quarter of its trading year, resulting in improved revenues for the group as a whole.
Verditek on Thursday signed a framework agreement with Engenera Renewables to advance commercial opportunities and jointly provide end-to-end solar solutions to clients.
Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of ‘SCIB1’ in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.
Water Intelligence on Thursday said it was optimistic for a "strong" first half of the year following contract wins in the US and Canada by its subsidiary, Water Intelligence International Limited (WII), including a contract in Flint, Michigan.
Commercial biotechnology company Allergy Therapeutics will kick off phase III trials of its short-course inoculation for grass pollen-induced hay fever in the second half of 2020 following a successful round of meetings with German and American regulatory bodies.
Image Scan Holdings shares leapt on Thursday after the company said it expects to meet full year expectations despite disappointing first-half sales.
Medical imaging technology outfit Feedback expects to report significant growth in revenues throughout its current trading year.
Data analytics firm Ixico expects half-year revenues to be in line with market expectations.
NetScientific chief executive François Martelet will depart the group on 30 April in order to assist the company in reducing its central costs and to pursue other career opportunities.
AB Dynamics nearly doubled its profits over the first half, even as it continued to expand its international footprint and invest for the future.
Sunrise Resources updated the market on some of its projects on Wednesday, saying that at the CS Pozzolan-Perlite Project, the latest testwork showed “promise” for the production of premium-value super-coarse horticultural grades of perlite.
Russia-focussed oil and gas exploration and production company PetroNeft updated the market on its 50%-owned licence 67 on Wednesday, reporting that new reserves had been approved for the licence in the Cheremshanskoye field.
Data analytics company Ixico has signed contracts with two biopharmaceutical companies to provide its technology-enabled imaging services to support an early phase study in Huntington's disease (HD), and a phase 3 study in another rare neurological disease.
Specialty pharmaceutical company Diurnal Group announced on Wednesday that its ‘Alkindi’ product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication ‘replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old’.
Pacific Rim-focussed natural resources exploration and development company Metals Exploration updated the market on its Runruno gold project in the Philippines on Wednesday, reporting mining of 2. 93Mt in the quarter ended 31 March, with total ore mined standing at 573Kt.
Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to ‘Periactin’ 4mg tablets from Merck and Company.
Mi-Pay Group's shares edged upwards on Wednesday as the company reported a reduction in annual loss as revenue crept up following the launch of its new fraud management service.
Midatech Pharma's shares dropped on Wednesday as the company reported an annual loss and falling cash balances, though it remained confident in its ability to create value over the next 18-24 months.
Exploration and production outfit Ascent Resources completed an oversubscribed placing of 214. 2m ordinary shares on Wednesday.